Viewing Study NCT00996593


Ignite Creation Date: 2025-12-25 @ 1:02 AM
Ignite Modification Date: 2025-12-26 @ 1:46 PM
Study NCT ID: NCT00996593
Status: COMPLETED
Last Update Posted: 2016-11-23
First Post: 2009-10-08
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Iodine-131 Anti-B1 Antibody for Patients With Non Hodgkin's Lymphoma Who Have Previously Received Rituximab
Sponsor: GlaxoSmithKline
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 1998-07
Start Date Type: None
Primary Completion Date: 2001-04
Primary Completion Date Type: ACTUAL
Completion Date: 2009-08
Completion Date Type: ACTUAL
First Submit Date: 2009-10-08
First Submit QC Date: None
Study First Post Date: 2009-10-16
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2011-12-21
Results First Submit QC Date: None
Results First Post Date: 2012-01-26
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2010-08-17
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2016-10-11
Last Update Post Date: 2016-11-23
Last Update Post Date Type: ESTIMATED